EV Biologics, Inc. (OTCMKTS:YECO) Sees Large Drop in Short Interest

EV Biologics, Inc. (OTCMKTS:YECO) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 100 shares, a drop of 75.0% from the February 29th total of 400 shares. Based on an average trading volume of 400 shares, the short-interest ratio is presently 0.3 days.

EV Biologics Price Performance

Shares of YECO opened at $0.70 on Friday. The company’s 50 day moving average price is $0.75 and its 200 day moving average price is $1.05. EV Biologics has a 52 week low of $0.70 and a 52 week high of $1.95.

EV Biologics Company Profile

EV Biologics, Inc, a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces.